Aquatic Capital Management’s Charles River Laboratories CRL Stock Holding History

Aquatic Capital Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-14,905	Closed	-$2.33M	–	1454
2025 Q3	$2.33M	Sell	14,905 -20,614	-58%	-$3.27M	0.04%	448
2025 Q2	$5.39M	Buy	35,519 +45	+0.1%	+$6K	0.11%	228
2025 Q1	$5.34M	Buy	35,474 +11,279	+47%	+$1.89M	0.14%	201
2024 Q4	$4.47M	Buy	+24,195	New	+$4.66M	0.12%	218
2023 Q2	–	Sell	-100	Closed	-$20K	–	1410
2023 Q1	$20K	Sell	100 -6,700	-99%	-$1.52M	﹤0.01%	1051
2022 Q4	$1.48M	Buy	+6,800	New	+$1.48M	0.11%	234
2022 Q3	–	Sell	-1,600	Closed	-$342K	–	1235
2022 Q2	$342K	Buy	+1,600	New	+$391K	0.11%	223
2022 Q1	–	Sell	-100	Closed	-$38K	–	1154
2021 Q4	$38K	Buy	+100	New	+$38.9K	0.07%	386

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Aquatic Capital Management's CRL Position: Q4 2025 in Review

Aquatic Capital Management sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 14,905 shares — an estimated $2.33M sold.

Aquatic Capital Management first reported a position in CRL in Q4 2021 and held it in 8 quarters. The position peaked at $5.39M in Q2 2025. 580 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

Aquatic Capital Management reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
Aquatic Capital Management sold 14,905 Charles River Laboratories shares in Q4 2025, an estimated $2.33M.
Aquatic Capital Management first reported a position in Charles River Laboratories in Q4 2021 and held it in 8 quarters.
Aquatic Capital Management's Charles River Laboratories position peaked at $5.39M in Q2 2025.
580 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on Aquatic Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.